Learn More
Cayman Chemical 4AmInobenzoIc ACD hydrazID

Supplier: Cayman Chemical 14845500 MG
An MPO inhibitor (IC50 = 0.3 µM); reduces opsonized zymosan- or PMA-induced HOCl production in isolated human neutrophils (IC50s = 16 and 2.2 µM, respectively); inhibits PMA-induced NET formation in the same cells; reduces infarct volume and the severity of neurological deficits, as well as increases survival, in a mouse model of transient MCAO-induced cerebral ischemia at 40 mg/kg twice per day
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.